{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:09:13Z","timestamp":1785496153859,"version":"3.56.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["(CNPq - 471312\/2012-6)"],"award-info":[{"award-number":["(CNPq - 471312\/2012-6)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12031-019-01408-7","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T22:21:15Z","timestamp":1572906075000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic Alterations in Patients with Two Clinical Phenotypes of Multiple Sclerosis"],"prefix":"10.1007","volume":"70","author":[{"given":"Luciana Maria","family":"Feliciano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz Ventura","family":"S\u00e1vio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo","family":"de Castro Marcondes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda Nicioli","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-3134","authenticated-orcid":false,"given":"Daisy Maria F\u00e1vero","family":"Salvadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2377-13-58","volume":"13","author":"E Alcalde-Cabero","year":"2013","unstructured":"Alcalde-Cabero E, Almaz\u00e1n-Isla J, Garc\u00eda-Merino A, de S\u00e1 J, de Pedro-Cuesta J (2013) Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring. BMC Neurol 13:58. \nhttps:\/\/doi.org\/10.1186\/1471-2377-13-58","journal-title":"BMC Neurol"},{"key":"1408_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.17712\/nsj.2015.4.20150357","volume":"20","author":"FM Alharbi","year":"2015","unstructured":"Alharbi FM (2015) Update in vitamin D and multiple sclerosis. Neurosciences 20:329\u2013335. \nhttps:\/\/doi.org\/10.17712\/nsj.2015.4.20150357","journal-title":"Neurosciences"},{"key":"1408_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","volume":"10","author":"F Baeke","year":"2010","unstructured":"Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10:482\u2013496. \nhttps:\/\/doi.org\/10.1016\/j.coph.2010.04.001","journal-title":"Curr Opin Pharmacol"},{"key":"1408_CR4","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.2174\/092986710793176339","volume":"17","author":"L Bertazza","year":"2010","unstructured":"Bertazza L, Mocellin S (2010) The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem 17:3337\u20133352","journal-title":"Curr Med Chem"},{"key":"1408_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/1352458513513968","volume":"20","author":"K Bj\u00f8rnevik","year":"2014","unstructured":"Bj\u00f8rnevik K, Riise T, Casetta I et al (2014) Sun exposure and multiple sclerosis risk in Norway and Italy: the EnvIMS study. Mult Scler Houndmills Basingstoke Engl 20:1042\u20131049. \nhttps:\/\/doi.org\/10.1177\/1352458513513968","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"1408_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.mrrev.2013.07.002","volume":"753","author":"C Bolognesi","year":"2013","unstructured":"Bolognesi C, Knasmueller S, Nersesyan A, Thomas P, Fenech M (2013) The HUMNxl scoring criteria for different cell types and nuclear anomalies in the buccal micronucleus cytome assay - an update and expanded photogallery. Mutat Res 753:100\u2013113. \nhttps:\/\/doi.org\/10.1016\/j.mrrev.2013.07.002","journal-title":"Mutat Res"},{"key":"1408_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2011.12.008","volume":"243","author":"Y-C Chen","year":"2012","unstructured":"Chen Y-C, Chen S-D, Miao L et al (2012) Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis. J Neuroimmunol 243:56\u201360. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2011.12.008","journal-title":"J Neuroimmunol"},{"key":"1408_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2011.05.024","volume":"307","author":"GP Christophi","year":"2011","unstructured":"Christophi GP, Christophi JA, Gruber RC et al (2011) Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-\u03b2 1a treated multiple sclerosis patients. J Neurol Sci 307:41\u201345. \nhttps:\/\/doi.org\/10.1016\/j.jns.2011.05.024","journal-title":"J Neurol Sci"},{"key":"1408_CR9","volume-title":"McAlpine\u2019s multiple sclerosis","author":"A Compston","year":"2005","unstructured":"Compston A, McDonald I, Noseworthy J et al (2005) McAlpine\u2019s multiple sclerosis, 4th edn. Churchill Livingstone Elsevier, Philadelphia","edition":"4"},{"key":"1408_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1874609811003010003","volume":"3","author":"F Copped\u00e8","year":"2010","unstructured":"Copped\u00e8 F, Migliore L (2010) DNA repair in premature aging disorders and neurodegeneration. Curr Aging Sci 3:3\u201319","journal-title":"Curr Aging Sci"},{"key":"1408_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.expneurol.2015.07.014","volume":"271","author":"C De Nuccio","year":"2015","unstructured":"De Nuccio C, Bernardo A, Cruciani C et al (2015) Peroxisome proliferator activated receptor-\u03b3 agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: effects on mitochondrial functions and differentiation. Exp Neurol 271:506\u2013514. \nhttps:\/\/doi.org\/10.1016\/j.expneurol.2015.07.014","journal-title":"Exp Neurol"},{"key":"1408_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/09553000410001723866","volume":"80","author":"VS Dhillon","year":"2004","unstructured":"Dhillon VS, Thomas P, Fenech M (2004) Comparison of DNA damage and repair following radiation challenge in buccal cells and lymphocytes using single-cell gel electrophoresis. Int J Radiat Biol 80:517\u2013528. \nhttps:\/\/doi.org\/10.1080\/09553000410001723866","journal-title":"Int J Radiat Biol"},{"key":"1408_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","volume":"7","author":"GC Ebers","year":"2008","unstructured":"Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7:268\u2013277. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(08)70042-5","journal-title":"Lancet Neurol"},{"key":"1408_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0027-5107(00)00065-8","volume":"455","author":"M Fenech","year":"2000","unstructured":"Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81\u201395","journal-title":"Mutat Res"},{"key":"1408_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","volume":"534","author":"M Fenech","year":"2003","unstructured":"Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E, HUman MicronNucleus project (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65\u201375","journal-title":"Mutat Res"},{"issue":"Suppl 1","key":"1408_CR16","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1016\/j.psyneuen.2009.05.023","volume":"34","author":"DA Fernandes de Abreu","year":"2009","unstructured":"Fernandes de Abreu DA, Eyles D, F\u00e9ron F (2009) Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 34(Suppl 1):S265\u2013S277. \nhttps:\/\/doi.org\/10.1016\/j.psyneuen.2009.05.023","journal-title":"Psychoneuroendocrinology"},{"key":"1408_CR17","doi-asserted-by":"publisher","first-page":"34512","DOI":"10.1038\/srep34512","volume":"6","author":"S Freiesleben","year":"2016","unstructured":"Freiesleben S, Hecker M, Zettl UK, Fuellen G, Taher L (2016) Analysis of microRNA and gene expression profiles in multiple sclerosis: integrating interaction data to uncover regulatory mechanisms. Sci Rep 6:34512. \nhttps:\/\/doi.org\/10.1038\/srep34512","journal-title":"Sci Rep"},{"key":"1408_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/glia.440150206","volume":"15","author":"J Gehrmann","year":"1995","unstructured":"Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J (1995) Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 15:141\u2013151. \nhttps:\/\/doi.org\/10.1002\/glia.440150206","journal-title":"Glia"},{"key":"1408_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/genes8030088","volume":"8","author":"JN Gnanaprakasam","year":"2017","unstructured":"Gnanaprakasam JN, Wang R (2017) MYC in regulating immunity: metabolism and beyond. Genes 8:88. \nhttps:\/\/doi.org\/10.3390\/genes8030088","journal-title":"Genes"},{"key":"1408_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/19381980.2016.1248325","volume":"8","author":"DG Hoel","year":"2016","unstructured":"Hoel DG, Berwick M, de Gruijl FR, Holick MF (2016) The risks and benefits of sun exposure 2016. Dermatoendocrinol 8:e1248325. \nhttps:\/\/doi.org\/10.1080\/19381980.2016.1248325","journal-title":"Dermatoendocrinol"},{"key":"1408_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jns.2011.09.024","volume":"313","author":"J Huang","year":"2012","unstructured":"Huang J, Xie Z-F (2012) Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies. J Neurol Sci 313:79\u201385. \nhttps:\/\/doi.org\/10.1016\/j.jns.2011.09.024","journal-title":"J Neurol Sci"},{"key":"1408_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1191\/1352458504ms1071oa","volume":"10","author":"W-X Huang","year":"2004","unstructured":"Huang W-X, Huang P, Hillert J (2004) Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 10:482\u2013487. \nhttps:\/\/doi.org\/10.1191\/1352458504ms1071oa","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"1408_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214\u2013219. \nhttps:\/\/doi.org\/10.1038\/nature10251","journal-title":"Nature"},{"key":"1408_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1212\/01.wnl.0000268266.50850.48","volume":"69","author":"T Islam","year":"2007","unstructured":"Islam T, Gauderman WJ, Cozen W, Mack TM (2007) Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 69:381\u2013388. \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000268266.50850.48","journal-title":"Neurology"},{"key":"1408_CR25","doi-asserted-by":"publisher","first-page":"15811","DOI":"10.1523\/JNEUROSCI.4088-10.2010","volume":"30","author":"S Jha","year":"2010","unstructured":"Jha S, Srivastava SY, Brickey WJ, Iocca H, Toews A, Morrison JP, Chen VS, Gris D, Matsushima GK, Ting JP (2010) The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci Off J Soc Neurosci 30:15811\u201315820. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.4088-10.2010","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1408_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jsbmb.2017.05.004","volume":"177","author":"R Jorde","year":"2018","unstructured":"Jorde R (2018) RCTS are the only appropriate way to demonstrate the role of vitamin D in health. J Steroid Biochem Mol Biol 177:10\u201314. \nhttps:\/\/doi.org\/10.1016\/j.jsbmb.2017.05.004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1408_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2377-13-128","volume":"13","author":"E Kingwell","year":"2013","unstructured":"Kingwell E, Marriott JJ, Jett\u00e9 N, Pringsheim T, Makhani N, Morrow SA, Fisk JD, Evans C, B\u00e9land SG, Kulaga S, Dykeman J, Wolfson C, Koch MW, Marrie RA (2013) Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 13:128. \nhttps:\/\/doi.org\/10.1186\/1471-2377-13-128","journal-title":"BMC Neurol"},{"key":"1408_CR28","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s00018-005-5022-6","volume":"62","author":"S Kodama","year":"2005","unstructured":"Kodama S, Davis M, Faustman DL (2005) The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cell Mol Life Sci CMLS 62:1850\u20131862. \nhttps:\/\/doi.org\/10.1007\/s00018-005-5022-6","journal-title":"Cell Mol Life Sci CMLS"},{"key":"1408_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ajhg.2008.01.009","volume":"82","author":"A Kulkarni","year":"2008","unstructured":"Kulkarni A, Wilson DM (2008) The involvement of DNA-damage and -repair defects in neurological dysfunction. Am J Hum Genet 82:539\u2013566. \nhttps:\/\/doi.org\/10.1016\/j.ajhg.2008.01.009","journal-title":"Am J Hum Genet"},{"key":"1408_CR30","doi-asserted-by":"publisher","unstructured":"Le Moan N, Baeten KM, Rafalski VA et al (2015) Hypoxia inducible factor-1\u03b1in astrocytes and\/or myeloid cells is not required for the development of autoimmune demyelinating disease. eNeuro 2. \nhttps:\/\/doi.org\/10.1523\/ENEURO.0050-14.2015","DOI":"10.1523\/ENEURO.0050-14.2015"},{"key":"1408_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1034\/j.1600-0404.2001.00356.x","volume":"104","author":"J Losy","year":"2001","unstructured":"Losy J, Niezgoda A (2001) IL-18 in patients with multiple sclerosis. Acta Neurol Scand 104:171\u2013173. \nhttps:\/\/doi.org\/10.1034\/j.1600-0404.2001.00356.x","journal-title":"Acta Neurol Scand"},{"key":"1408_CR32","first-page":"907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907\u20139113","journal-title":"National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology"},{"key":"1408_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278\u2013286. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"key":"1408_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jneuroim.2004.06.008","volume":"155","author":"BT Lund","year":"2004","unstructured":"Lund BT, Ashikian N, Ta HQ et al (2004) Increased CXCL8 (IL-8) expression in multiple sclerosis. J Neuroimmunol 155:161\u2013171. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2004.06.008","journal-title":"J Neuroimmunol"},{"key":"1408_CR35","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.jocn.2014.04.020","volume":"21","author":"B Mansouri","year":"2014","unstructured":"Mansouri B, Asadollahi S, Heidari K et al (2014) Risk factors for increased multiple sclerosis susceptibility in the Iranian population. J Clin Neurosci Off J Neurosurg Soc Australas 21:2207\u20132211. \nhttps:\/\/doi.org\/10.1016\/j.jocn.2014.04.020","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"1408_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/1941874412457183","volume":"3","author":"JF Marcus","year":"2013","unstructured":"Marcus JF, Waubant EL (2013) Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. The Neurohospitalist 3:65\u201380. \nhttps:\/\/doi.org\/10.1177\/1941874412457183","journal-title":"The Neurohospitalist"},{"key":"1408_CR37","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1093\/brain\/awm236","volume":"130","author":"C Marik","year":"2007","unstructured":"Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain J Neurol 130:2800\u20132815. \nhttps:\/\/doi.org\/10.1093\/brain\/awm236","journal-title":"Brain J Neurol"},{"key":"1408_CR38","doi-asserted-by":"publisher","unstructured":"Mat\u00edas-Guiu JA, Oreja-Guevara C, Cabrera-Mart\u00edn MN et al (2016) Amyloid proteins and their role in multiple sclerosis. Considerations in the use of amyloid-PET Imaging. Front Neurol 7. \nhttps:\/\/doi.org\/10.3389\/fneur.2016.00053","DOI":"10.3389\/fneur.2016.00053"},{"key":"1408_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/mutage\/geq067","volume":"26","author":"L Migliore","year":"2011","unstructured":"Migliore L, Copped\u00e8 F, Fenech M, Thomas P (2011) Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis 26:85\u201392. \nhttps:\/\/doi.org\/10.1093\/mutage\/geq067","journal-title":"Mutagenesis"},{"key":"1408_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mrfmmm.2013.08.004","volume":"749","author":"M Milenkova","year":"2013","unstructured":"Milenkova M, Milanov I, Kmetska K, Deleva S, Popova L, Hadjidekova V, Groudeva V, Hadjidekova S, Dom\u00ednguez I (2013) Chromosomal radiosensitivity in patients with multiple sclerosis. Mutat Res 749:3\u20138. \nhttps:\/\/doi.org\/10.1016\/j.mrfmmm.2013.08.004","journal-title":"Mutat Res"},{"key":"1408_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10238-008-0161-3","volume":"8","author":"EM Minicucci","year":"2008","unstructured":"Minicucci EM, Ribeiro DA, de Camargo B, Costa MC, Ribeiro LR, Favero Salvadori DM (2008) DNA damage in lymphocytes and buccal mucosa cells of children with malignant tumours undergoing chemotherapy. Clin Exp Med 8:79\u201385. \nhttps:\/\/doi.org\/10.1007\/s10238-008-0161-3","journal-title":"Clin Exp Med"},{"key":"1408_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11481-011-9287-2","volume":"7","author":"SL Montgomery","year":"2012","unstructured":"Montgomery SL, Bowers WJ (2012) Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 7:42\u201359. \nhttps:\/\/doi.org\/10.1007\/s11481-011-9287-2","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"1408_CR43","unstructured":"MSIF (2013) Multiple Sclerosis International Federation. Atlas of MS in 2013. Mapping multiple sclerosis around the world. Modern Colour Solutions"},{"key":"1408_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/TACG.S29107","volume":"6","author":"M Mu\u00f1oz-Culla","year":"2013","unstructured":"Mu\u00f1oz-Culla M, Irizar H, Otaegui D (2013) The genetics of multiple sclerosis: review of current and emerging candidates. Appl Clin Genet 6:63\u201373. \nhttps:\/\/doi.org\/10.2147\/TACG.S29107","journal-title":"Appl Clin Genet"},{"key":"1408_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000317393","volume":"18","author":"U Musabak","year":"2011","unstructured":"Musabak U, Demirkaya S, Gen\u00e7 G, Ilikci RS, Odabasi Z (2011) Serum adiponectin, TNF-\u03b1, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens. Neuroimmunomodulation 18:57\u201366. \nhttps:\/\/doi.org\/10.1159\/000317393","journal-title":"Neuroimmunomodulation"},{"key":"1408_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.intimp.2015.06.033","volume":"28","author":"B Naghavi Gargari","year":"2015","unstructured":"Naghavi Gargari B, Behmanesh M, Shirvani Farsani Z, Pahlevan Kakhki M, Azimi AR (2015) Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients. Int Immunopharmacol 28:414\u2013419. \nhttps:\/\/doi.org\/10.1016\/j.intimp.2015.06.033","journal-title":"Int Immunopharmacol"},{"key":"1408_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00430-015-0437-7","volume":"205","author":"A Nejati","year":"2016","unstructured":"Nejati A, Shoja Z, Shahmahmoodi S, Tafakhori A, Mollaei-Kandelous Y, Rezaei F, Hamid KM, Mirshafiey A, Doosti R, Sahraian MA, Mahmoudi M, Shokri F, Emery V, Marashi SM (2016) EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature. Med Microbiol Immunol (Berl) 205:143\u2013154. \nhttps:\/\/doi.org\/10.1007\/s00430-015-0437-7","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"1408_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fimmu.2017.00425","volume":"8","author":"GP Parnell","year":"2017","unstructured":"Parnell GP, Booth DR (2017) The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities. Front Immunol 8:425. \nhttps:\/\/doi.org\/10.3389\/fimmu.2017.00425","journal-title":"Front Immunol"},{"key":"1408_CR49","first-page":"186","volume":"13","author":"F Peiravian","year":"2016","unstructured":"Peiravian F, Rajaian H, Samiei A et al (2016) Altered serum cytokine profiles in relapse phase of relapsing-remitting multiple sclerosis. Iran J Immunol IJI 13:186\u2013196 IJIv13i3A4","journal-title":"Iran J Immunol IJI"},{"key":"1408_CR50","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s00415-009-5139-x","volume":"256","author":"C Pierrot-Deseilligny","year":"2009","unstructured":"Pierrot-Deseilligny C (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 256:1468\u20131479. \nhttps:\/\/doi.org\/10.1007\/s00415-009-5139-x","journal-title":"J Neurol"},{"key":"1408_CR51","doi-asserted-by":"publisher","unstructured":"Pietroboni AM, di Cola FS, Scarioni M et al (2017) CSF \u03b2-amyloid as a putative biomarker of disease progression in multiple sclerosis. Multiple Sclerosis J 23:1085\u20131091. \nhttps:\/\/doi.org\/10.1177\/1352458516674566","DOI":"10.1177\/1352458516674566"},{"key":"1408_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.rdc.2012.03.004","volume":"38","author":"JW Pike","year":"2012","unstructured":"Pike JW, Meyer MB (2012) The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum Dis Clin North Am 38:13\u201327. \nhttps:\/\/doi.org\/10.1016\/j.rdc.2012.03.004","journal-title":"Rheum Dis Clin North Am"},{"key":"1408_CR53","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302. \nhttps:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"key":"1408_CR54","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/nu5072502","volume":"5","author":"B Prietl","year":"2013","unstructured":"Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients 5:2502\u20132521. \nhttps:\/\/doi.org\/10.3390\/nu5072502","journal-title":"Nutrients"},{"key":"1408_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nature21107","volume":"541","author":"CA Ross","year":"2017","unstructured":"Ross CA, Truant R (2017) DNA repair: a unifying mechanism in neurodegeneration. Nature 541:34\u201335. \nhttps:\/\/doi.org\/10.1038\/nature21107","journal-title":"Nature"},{"key":"1408_CR56","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/1352458513498128","volume":"20","author":"S Rossi","year":"2014","unstructured":"Rossi S, Motta C, Studer V et al (2014) Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Mult Scler Houndmills Basingstoke Engl 20:304\u2013312. \nhttps:\/\/doi.org\/10.1177\/1352458513498128","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"1408_CR57","doi-asserted-by":"publisher","unstructured":"Sadeghi H, Taheri M, Sajjadi E et al (2017) VDR and CYP24A1 expression analysis in Iranian relapsing-remitting multiple sclerosis patients. Cell J Yakhteh:352\u2013360. \nhttps:\/\/doi.org\/10.22074\/cellj.2017.4192","DOI":"10.22074\/cellj.2017.4192"},{"key":"1408_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/jnnp-2012-304333","volume":"85","author":"A Scalfari","year":"2014","unstructured":"Scalfari A, Neuhaus A, Daumer M et al (2014) Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 85:67\u201375. \nhttps:\/\/doi.org\/10.1136\/jnnp-2012-304333","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1408_CR59","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.neurobiolaging.2005.03.009","volume":"27","author":"DA Shackelford","year":"2006","unstructured":"Shackelford DA (2006) DNA end joining activity is reduced in Alzheimer\u2019s disease. Neurobiol Aging 27:596\u2013605. \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.03.009","journal-title":"Neurobiol Aging"},{"key":"1408_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.22043","volume":"68","author":"S Simpson","year":"2010","unstructured":"Simpson S, Taylor B, Blizzard L et al (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68:193\u2013203. \nhttps:\/\/doi.org\/10.1002\/ana.22043","journal-title":"Ann Neurol"},{"key":"1408_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2011.03.012","volume":"235","author":"J Smolders","year":"2011","unstructured":"Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J (2011) Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. J Neuroimmunol 235:91\u201397. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2011.03.012","journal-title":"J Neuroimmunol"},{"key":"1408_CR62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","volume":"9","author":"J-C Souberbielle","year":"2010","unstructured":"Souberbielle J-C, Body J-J, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Gu\u00e9rin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9:709\u2013715. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2010.06.009","journal-title":"Autoimmun Rev"},{"key":"1408_CR63","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/brain\/awh457","volume":"128","author":"C Stadelmann","year":"2005","unstructured":"Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, Ordinario AT, Br\u00fcck W, Lassmann H (2005) Tissue preconditioning may explain concentric lesions in Bal\u00f3\u2019s type of multiple sclerosis. Brain J Neurol 128:979\u2013987. \nhttps:\/\/doi.org\/10.1093\/brain\/awh457","journal-title":"Brain J Neurol"},{"key":"1408_CR64","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.clinph.2017.04.006","volume":"128","author":"MB Stampanoni","year":"2017","unstructured":"Stampanoni MB, Mori F, Buttari F et al (2017) Neurophysiology of synaptic functioning in multiple sclerosis. Clin Neurophysiol Off J Int Fed Clin Neurophysiol 128:1148\u20131157. \nhttps:\/\/doi.org\/10.1016\/j.clinph.2017.04.006","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"1408_CR65","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanct\u00f4t K, Rothenburg L et al (2010) A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry 68:930\u2013941. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2010.06.012","journal-title":"Biol Psychiatry"},{"key":"1408_CR66","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/mutage\/gem029","volume":"22","author":"P Thomas","year":"2007","unstructured":"Thomas P, Hecker J, Faunt J, Fenech M (2007) Buccal micronucleus cytome biomarkers may be associated with Alzheimer\u2019s disease. Mutagenesis 22:371\u2013379. \nhttps:\/\/doi.org\/10.1093\/mutage\/gem029","journal-title":"Mutagenesis"},{"key":"1408_CR67","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nprot.2009.53","volume":"4","author":"P Thomas","year":"2009","unstructured":"Thomas P, Holland N, Bolognesi C et al (2009) Buccal micronucleus cytome assay. Nat Protoc 4:825\u2013837. \nhttps:\/\/doi.org\/10.1038\/nprot.2009.53","journal-title":"Nat Protoc"},{"key":"1408_CR68","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1093\/nar\/gkm605","volume":"35","author":"L Weissman","year":"2007","unstructured":"Weissman L, Jo D-G, S\u00f8rensen MM, de Souza-Pinto NC, Markesbery WR, Mattson MP, Bohr VA (2007) Defective DNA base excision repair in brain from individuals with Alzheimer\u2019s disease and amnestic mild cognitive impairment. Nucleic Acids Res 35:5545\u20135555. \nhttps:\/\/doi.org\/10.1093\/nar\/gkm605","journal-title":"Nucleic Acids Res"},{"key":"1408_CR69","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/01616412.2016.1250857","volume":"39","author":"Q Yang","year":"2017","unstructured":"Yang Q, Pan W, Qian L (2017) Identification of the miRNA\u2013mRNA regulatory network in multiple sclerosis. Neurol Res 39:142\u2013151. \nhttps:\/\/doi.org\/10.1080\/01616412.2016.1250857","journal-title":"Neurol Res"},{"key":"1408_CR70","doi-asserted-by":"publisher","first-page":"w13192","DOI":"10.4414\/smw.2011.13192","volume":"141","author":"M Yildiz","year":"2011","unstructured":"Yildiz M, Tettenborn B, Putzki N (2011) Vitamin D levels in Swiss multiple sclerosis patients. Swiss Med Wkly 141:w13192. \nhttps:\/\/doi.org\/10.4414\/smw.2011.13192","journal-title":"Swiss Med Wkly"},{"key":"1408_CR71","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/brain\/awm291","volume":"131","author":"T Zeis","year":"2008","unstructured":"Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N (2008) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain J Neurol 131:288\u2013303. \nhttps:\/\/doi.org\/10.1093\/brain\/awm291","journal-title":"Brain J Neurol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-019-01408-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-019-01408-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-019-01408-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:51:24Z","timestamp":1604364684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-019-01408-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1007\/s12031-019-01408-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The Ethics Committee on Human Research of the Faculty of Medicine of Botucatu, (FMB)-UNESP approved the study protocol (CEP-4072-2011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}}]}}